Page last updated: 2024-11-06

3,3',5-triiodothyroacetic acid and Congenital Zika Syndrome

3,3',5-triiodothyroacetic acid has been researched along with Congenital Zika Syndrome in 2 studies

tiratricol : A monocarboxylic acid that is (4-hydroxy-3,5-diiodophenyl)acetic acid in which the phenolic hydroxy group has been replaced by a 4-hydroxy-3-iodophenoxy group. It is a thyroid hormone analogue that has been used in the treatment of thyroid hormone resistance syndrome.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Abrams, RPM1
Yasgar, A1
Teramoto, T1
Lee, MH1
Dorjsuren, D1
Eastman, RT1
Malik, N1
Zakharov, AV1
Li, W1
Bachani, M1
Brimacombe, K1
Steiner, JP1
Hall, MD1
Balasubramanian, A1
Jadhav, A1
Padmanabhan, R1
Simeonov, A1
Nath, A1
Ren, H1
Wang, J1
Tang, H1
Qian, X1
Xia, B1
Luo, Z1
Xu, Z1
Qi, Z1
Zhao, P1

Other Studies

2 other studies available for 3,3',5-triiodothyroacetic acid and Congenital Zika Syndrome

ArticleYear
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 12-08, Volume: 117, Issue:49

    Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Dr

2020
Tiratricol inhibits yellow fever virus replication through targeting viral RNA-dependent RNA polymerase of NS5.
    Antiviral research, 2023, Volume: 219

    Topics: Animals; Antiviral Agents; Humans; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; RNA-Depen

2023